-
1.发明授权
公开(公告)号：US3535348A
公开(公告)日：1970-10-20
申请号：US3535348D
申请日：1967-07-31
Applicant: UPJOHN CO
Inventor： JACKSON ROBERT W , BABCOCK JOHN C
IPC: A61K31/573 , C07J41/00 , C07J75/00 , C07C167/00
CPC classification number: A61K31/573 , C07J41/00 , C07J75/00
-
2.发明授权Oral,parenteral and inhalation-therapy with 3,11-dioxo-4,17(20)-cis-pregnadien-21-oic acid,methyl ester,3-oxime 失效口服，使用3,11-二氧代-4,17（20）-CIS-孕酮-21-酸，甲酯，3-氧化物的口服和吸入治疗
公开(公告)号：US3539683A
公开(公告)日：1970-11-10
申请号：US3539683D
申请日：1968-09-26
Applicant: UPJOHN CO
Inventor： JACKSON ROBERT W , BABCOCK JOHN C
IPC: A61K31/573 , C07J41/00 , C07J75/00 , A61K17/00
CPC classification number: A61K31/573 , C07J41/00 , C07J75/00
-
3.发明授权Process for the production of 8(9)-dehydroprogesterone and 9alpha-hydroxyprogesterone 失效生产8（9） - 脱氢孕酮和9α-羟孕酮的方法
公开(公告)号：US3040065A
公开(公告)日：1962-06-19
申请号：US72487458
申请日：1958-03-31
Applicant: UPJOHN CO
Inventor： SCHNEIDER WILLIAM P , JACKSON ROBERT W
CPC classification number: C07J5/00 , C07J75/00 , Y10S435/911 , Y10S435/939
-
公开(公告)号：US3021327A
公开(公告)日：1962-02-13
申请号：US12538661
申请日：1961-07-20
Applicant: UPJOHN CO
Inventor： BEAL ILL PHILIP F , JACKSON ROBERT W
-
公开(公告)号：US2838502A
公开(公告)日：1958-06-10
申请号：US69950857
申请日：1957-11-29
Applicant: UPJOHN CO
Inventor： BEAL PHILIP F , HOGG JOHN A , JACKSON ROBERT W
-
Patent Agency Ranking
公开(公告)号：US3642800A
公开(公告)日：1972-02-15
申请号：US3642800D
申请日：1969-07-28
Applicant: UPJOHN CO
Inventor： NELSON NORMAN A , JACKSON ROBERT W
IPC: C07C62/32 , C07D221/18 , C07J1/00 , C07J73/00 , C07D33/02
CPC classification number: C07C62/32 , C07C2603/48 , C07D221/18 , C07J1/0011 , C07J73/005
Abstract: THIS INVENTION RELATES TO NOVEL NITROGEN CONTAINING RINGD SECO STEROID TRANSFORMATION PRODUCTS OF THE FOLLOWING FORMULA AND TO PROCESSES FOR THEIR PREPARATION:
2-(O=),4A-(CH3-),7-(CH3-),7-(HO-CH2-),8,9-(-(CH2)N-CH2-
N(-R)-)-2,3,4,4A,4B,5,6,7,8,8A,9,10-DODECAHYDRO
PHENANTHRENE
WHEREIN N IS THE WHOLE NUMBER 2 OR 3 AND R IS HYDROGEN OR LOWER-ALKYL, AND THE PHARMACOLOGICALLY ACCEPTABLE ACID ADDITION SALTS TGHEREOF. THE COMPOUNDS OF THE ABORE STRUCTURAL FORMULA XI ARE CENTRAL NEVOUS SYSTEM STIMULANTS.-
公开(公告)号：US3147248A
公开(公告)日：1964-09-01
申请号：US12536461
申请日：1961-07-20
Applicant: UPJOHN CO
Inventor： BEAL III PHILIP F , JACKSON ROBERT W
-
公开(公告)号：US2799688A
公开(公告)日：1957-07-16
申请号：US47606054
申请日：1954-12-17
Applicant: UPJOHN CO
Inventor： JACKSON ROBERT W , HOGG JOHN A
-
公开(公告)号：US3634419A
公开(公告)日：1972-01-11
申请号：US3634419D
申请日：1969-07-28
Applicant: UPJOHN CO
Inventor： NELSON NORMAN A , JACKSON ROBERT W
IPC: C07D209/58 , C07D498/08 , C07D27/30
CPC classification number: C07D209/58
Abstract: THIS INVENTION RELATES TO NOVEL 17-AZASTEROIDS, TO PROESSES FOR THEIR PREPARATION AND MORE PARTICULARLY TO COMPOUNDS EMBRACED BY THE FOLLOWING FORMULA:
1,2-(-X-CH2-CH(-)-N(-Z)-CH2-CH2-CH(-)-),6-(O=),8A-(CH3-)
1,2,6,7,8,8A-HEXAHYDRONAPHTHALENE
WHEREIN Z IS HYDROGEN, ALKYL,-SO2R, IN WHICH R IS ALKYL OR ARYL, -COR1, IN WHICH R1 IS ALKYL, AND -COOR1 IN WHICH R1 IS ALKYL, AND X IS CARBONYL (>C=O), A-HYDROXYMETHYLENE
-C(-H)(--OH)- OR -C(--H)(-OH)-
AND THE PHARMACOLOGICALLY ACCEPTABLE ACID ADDITION SALTS OF THOSE COMPOUNDS OF FORMULA V, ABOVE, WHEREIN Z IS HYDROGEN OR ALKYL. THE COMPOUNDS OF THE ABOVE FORMULA V ARE ANTI-INFLAMMATORY AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS, AND ANTIFUNGAL AND ANTIMICROBIAL AGENTS.-
10.发明授权14alpha,15alpha-ketonides of alkyl 3-oxygenated-14alpha,15alpha-dihydroxy -4,17(20)-cis-pregnadien-21-oates,derivatives thereof,and intermediates and processes therefor 失效14ALPHA，烷基3-氧化-14ALPHA，15ALPHA-二羟基-4,17（20）-CIS-孕酮-2-甲酸酯，其衍生物及其中间体及其过程的15ALPHA-酮
公开(公告)号：US3502659A
公开(公告)日：1970-03-24
申请号：US3502659D
申请日：1967-04-03
Applicant: UPJOHN CO
Inventor： BEAL PHILIP F , JACKSON ROBERT W
IPC: A61K31/573 , A61K31/58 , C07C173/00 , C07C169/00
CPC classification number: A61K31/573 , A61K31/58 , Y10S435/933
-
-
-
-
-
-
-
-
-
Search Results
13
records
(took 0.009 seconds)
